RCUS- Arcus Biosciences, Inc.

Name: Arcus Biosciences, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Arcus Biosciences, Inc. (RCUS) has 7 insiders with recent SEC Form 4 filings, including 14 buys and 2 sells. RCUS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Rosen Terry J	2.16M	$58.75M	-
Pres	Jaen Juan C.	922.3K	$25.12M	-
COO	Jarrett Jennifer	193.0K	$5.26M	-
Other	Tang Carolyn C.	124.7K	$3.40M	-
CFO	Goeltz II Robert C.	67.9K	$1.85M	-

Activity

Buys and sells only

Transactions

10 filings · page 8

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 16, 2021	Jarrett Jennifer74	Chief Operating Officer	Sell	8,661	$35.03	$303,393.96	-6.9%	-29.8%	-4.6%
Dec 16, 2020	Grossman William60	Chief Medical Officer	Sell	2,117	$31.35	$66,367.95	-23.9%	-	-
Sep 9, 2020	Goeltz II Robert C.72	Chief Financial Officer	Buy	5,000	$21.57	$107,848.50	New	-	-
Aug 10, 2020	Rosen Terry J72	Chief Executive Officer	Buy	43,705	$22.86	$999,313.89	+0.7%	-	-
Jul 31, 2020	Grossman William60	Chief Medical Officer	Buy	200	$19.72	$3,944.56	+22.2%	-	-
Oct 14, 2019	Grossman William60	Chief Medical Officer	Buy	400	$8.00	$3,200.00	+400.0%	-	-
Jun 28, 2019	Jaen Juan C.75	President	Buy	15,000	$7.59	$113,853.60	+0.3%	-	-
Jun 13, 2019	Falberg Kathryn E53	Director	Buy	12,935	$8.52	$110,151.87	+18.7%	-	-
Jun 12, 2019	Falberg Kathryn E53	Director	Buy	20,000	$8.20	$163,928.00	+18.5%	-	-
Jun 10, 2019	Falberg Kathryn E53	Director	Buy	32,065	$8.07	$258,797.14	+57.0%	-	-

← PrevPage 8Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC